Effect duloxetine versus amitriptyline on clinical outcomes of female with chronic pelvic pain syndrome
Phase 3
Recruiting
- Conditions
- Chronic pelvic pain syndrome.Pelvic and perineal painR10.2
- Registration Number
- IRCT20120215009014N457
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 48
Inclusion Criteria
Age 18 to 50 years
Chronic pelvic pain syndrome for more than 6 months
Exclusion Criteria
Pregnancy or breastfeeding
Suffering from endometriosis, ovarian cyst, adenomyosis, fibroid or genital malignancy
Gastrointestinal diseases including irritable bowel syndrome or inflammatory bowel disease
History of previous hip surgery
Genitourinary infection
Cognitive or mental disorders
Kidney and liver dysfunction
History of alcohol and substance abuse
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of clinical symptoms (pain, difficulty in defecation). Timepoint: Before the intervention and one and two months after that. Method of measurement: Using the National Institutes of Health Chronic Syndrome Symptom Index (NIH-CSSI).;The rate of overall response to treatment. Timepoint: Two months after the intervention. Method of measurement: Using the Global Response Assessment (GRA) questionnaire.
- Secondary Outcome Measures
Name Time Method Occurrence of side effects (nausea, vomiting). Timepoint: one and two months after intervention. Method of measurement: With history taking.